Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Effects of T-REX Twente precautions on recovery after heart surgery

Official title: A Randomized Clinical Trial to Study the "T-REX Twente Regimen" (Thoracic Surgery Rehabilitation Experts Twente) on Quality of Life and Mobilisation Activities for Cardiac Surgery Patients After Median Sternotomy, Compared to Usual Care

Run by Medisch Spectrum Twente · NCT06115759 · Data updated 2026-11-12

This study is testing if following new T-REX Twente precautions helps people recover better and feel less afraid of moving after heart surgery compared to standard care.

More Cardiovascular Diseases trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment154 (estimated)
SponsorMedisch Spectrum Twente
Academic / other
Locations1 site (Enschede, Overijssel)
StatusRecruiting
StartedMay 21, 2024
Main results expectedJanuary 2026
Study endsMarch 2026
Registry record updatedFebruary 7, 2025
Trial IDNCT06115759 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adult patients undergoing total median sternotomy at Thorax Centrum Twente.

Probably not a fit

Patients with significant cognitive disorders, language barriers, or those admitted to the ICU for more than 72 hours may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates whether the T-REX Twente precautions improve quality of life, physical activity, and reduce fear of movement in patients recovering from total median sternotomy compared to standard precautions. Participants will be randomly assigned to either the intervention group, which follows the new T-REX precautions, or the control group, which adheres to traditional restrictive precautions. Data will be collected through questionnaires assessing quality of life and mobility during the hospital stay and outpatient rehabilitation. The study aims to determine if the new approach leads to better recovery outcomes without increasing pain or complications.

Why it matters

Potential benefit: If successful, this study could enhance recovery and quality of life for cardiac surgery patients by allowing more independence during rehabilitation.

How similar studies have gone: Previous studies have suggested that less restrictive precautions may be safe and beneficial, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients who are preoperatively included if they are undergoing a total median sternotomy at Thorax Centrum Twente (TCT)
* Patients with their treating cardiologist also working for TCT.

Exclusion Criteria:

* \>72 hours of admission to the Intensive Care Unit (ICU)
* Postoperative delirium (diagnosed with Diagnostic and Statistical Manual of Mental Disorders (DSM) version V
* Patients with dementia (or other significant cognitive disorders)
* Dutch language barriers
* Patients with a cardiologist from a location other than TCT

Where it's running

  • Thoraxcentrum Twente
    Enschede, Overijssel, Netherlands
    Recruiting

Study contacts

  • Principal investigator: Frank R. Halfwerk, MD, PhD — Medisch Spectrum Twente, Enschede, the Netherlands
  • Study coordinator: Nicole Wielens, BSc
  • Email: n.wielens@mst.nl
  • Phone: 0031615060570

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.